TLRY
Closed
Tilray Inc
0.4216
+0.0072 (+1.74%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 0.4144
Day's Range: 0.407 - 0.425
Send
sign up or login to leave a comment!
When Written:
2.52
Tilray Inc. is a Canadian pharmaceutical and cannabis company that was founded in 2013. The company is headquartered in Nanaimo, British Columbia, and it operates in several countries, including Canada, the United States, Europe, and Australia. Tilray produces and distributes medical and recreational cannabis products, as well as pharmaceutical products that are derived from cannabis.
Tilray is one of the largest cannabis companies in the world, with a market capitalization of over $4 billion. The company's products are sold under several brands, including Tilray, Marley Natural, and Goodship. Tilray has partnerships with several major companies, including Novartis, Anheuser-Busch InBev, and Authentic Brands Group.
Tilray is also involved in research and development of cannabis-based medicines, and it has conducted several clinical trials to investigate the therapeutic potential of cannabis. The company is focused on developing treatments for conditions such as epilepsy, multiple sclerosis, and cancer.
In 2018, Tilray became the first cannabis company to go public on the NASDAQ stock exchange, and its shares are also traded on the Toronto Stock Exchange. The company has experienced significant growth in recent years, driven by the legalization of cannabis in several countries, including Canada and many states in the United States.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Tilray is one of the largest cannabis companies in the world, with a market capitalization of over $4 billion. The company's products are sold under several brands, including Tilray, Marley Natural, and Goodship. Tilray has partnerships with several major companies, including Novartis, Anheuser-Busch InBev, and Authentic Brands Group.
Tilray is also involved in research and development of cannabis-based medicines, and it has conducted several clinical trials to investigate the therapeutic potential of cannabis. The company is focused on developing treatments for conditions such as epilepsy, multiple sclerosis, and cancer.
In 2018, Tilray became the first cannabis company to go public on the NASDAQ stock exchange, and its shares are also traded on the Toronto Stock Exchange. The company has experienced significant growth in recent years, driven by the legalization of cannabis in several countries, including Canada and many states in the United States.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!